CEO & President

Senior Vice President, Chief Commercial Officer

Taiho Oncology and Cullinan Therapeutics Present Data on Zipalertinib at the IASLC 2025 World Conference on Lung Cancer

FGFR Inhibitors Market Set to Surge by 2034 as Targeted Cancer Therapies Transform Treatment Paradigms | DelveInsight

Cholangiocarcinoma Market Analysis Report 2025-2035 | Rising Incidence, Advanced Diagnostics, and Precision Medicine Driving Novel Therapeutic Development

ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025

Regional Business Director

Taiho Oncology, Inc. is dedicated to improving the lives of cancer patients and their families through innovative science and a strong commitment to their employees. The Regional Business Director will lead the Oncology Account Managers in the Northeast region, focusing on driving sales of approved products and developing strategic business plans to meet customer needs.

Sign up with Google

Sign in with Google